CIK 0001205922 · Non-accelerated filer<br>Smaller reporting company
VACCINEX, INC.
Sign in to watch- Ticker
- VCNX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 161603202
- Phone
- 585-271-2700
- Business address
- 1895 MOUNT HOPE AVE, ROCHESTER, NY, 14620
- Former names
- VACCINEX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 54 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-11 | Van Strydonck, Gerald E. Director | Grant or award · Stock Option (Right to Buy) | +28,586 | 28,586 | ||
| 2021-05-11 | Frieberg Jacob B. Director | Grant or award · Stock Option (Right to Buy) | +28,586 | 28,586 | ||
| 2021-04-02 | Royer Scott E. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +6,000 | 6,000 | ||
| 2021-04-02 | Zauderer Maurice President and CEO | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2021-04-02 | Leonard John E. SVP, Development | Grant or award · Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2021-04-02 | Smith Ernest S. SVP, Research & CSO | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-03-31 | Frieberg Jacob B. Director | Grant or award · Stock Option (Right to Buy) | +4,535 | 4,535 | ||
| 2020-12-31 | Frieberg Jacob B. Director | Grant or award · Stock Option (Right to Buy) | +6,545 | 6,545 | ||
| 2020-09-30 | Frieberg Jacob B. Director | Grant or award · Stock Option (Right to Buy) | +7,626 | 7,626 | ||
| 2020-09-03 | Royer Scott E. Chief Financial Officer | Option exercise | +500 | $3.90 | $2K | 4,499 |
| 2020-09-03 | Royer Scott E. Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −500 | 1,500 | ||
| 2020-09-01 | Scala Robert Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2020-07-27 | Leonard John E. SVP, Development | Option exercise | +1,000 | $3.90 | $4K | 2,258 |
| 2020-07-27 | Leonard John E. SVP, Development | Option exercise · Stock Option (Right to Buy) | −1,000 | 3,000 | ||
| 2020-07-27 | Leonard John E. SVP, Development | Option exercise | +1,000 | $3.90 | $4K | 1,000 |
| 2020-07-27 | Leonard John E. SVP, Development | Option exercise · Stock Option (Right to Buy) | −1,000 | 3,000 | ||
| 2020-07-24 | Leonard John E. SVP, Development | Option exercise | +1,258 | $7.10 | $9K | 1,258 |
| 2020-07-24 | Leonard John E. SVP, Development | Option exercise · Stock Option (Right to Buy) | −1,258 | 23,150 | ||
| 2020-07-14 | Leonard John E. SVP, Development | Option exercise | +1,000 | $3.90 | $4K | 2,258 |
| 2020-07-14 | Leonard John E. SVP, Development | Option exercise · Stock Option (Right to Buy) | −1,000 | 3,000 |
Page 7 of 8 · 146 trades